Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Greiner

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Leukemia|March 31, 2021
Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemiaGregor Eisenwort, Irina Sadovnik, Alexandra Keller, et al.
Blood Advances|October 21, 2020
Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CMLHarald Herrmann, Irina Sadovnik, Gregor Eisenwort, et al.
Blood|July 19, 2018
CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosisNiklas Mueller, Daniel Wicklein, Gregor Eisenwort, et al.
Cancers|July 9, 2022
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in <i>KIT</i> D816V<sup>+</sup> Neoplastic Mast CellsMathias Schneeweiss-Gleixner, Yüksel Filik, Gabriele Stefanzl, et al.
Frontiers in Pediatrics|March 11, 2020
A Multidisciplinary Intervention in Childhood Obesity Acutely Improves Insulin Resistance and Inflammatory Markers Independent From Body CompositionErnst Mayerhofer, Franz Ratzinger, Nina Elvira Kienreich, et al.
American Journal of Hematology|July 7, 2022
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph<sup>+</sup> chronic myeloid leukemiaBarbara Peter, Gregor Eisenwort, Irina Sadovnik, et al.
Plos One|July 26, 2017
Fasting metabolism modulates the interleukin-12/interleukin-10 cytokine axisJohannes J Kovarik, Elisabeth Kernbauer, Markus A Hölzl, et al.
Haematologica|February 14, 2018
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosisMathias Schneeweiss, Barbara Peter, Siham Bibi, et al.
American Journal of Cancer Research|March 10, 2023
Antineoplastic efficacy profiles of avapritinib and nintedanib in <i>KIT</i> D816V<sup>+</sup> systemic mastocytosis: a preclinical studyLina Degenfeld-Schonburg, Susanne Gamperl, Gabriele Stefanzl, et al.
Blood|August 11, 2020
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosisGeorg Greiner, Bettina Sprinzl, Aleksandra Górska, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Leukemia|March 31, 2021
Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemiaGregor Eisenwort, Irina Sadovnik, Alexandra Keller, et al.
Blood Advances|October 21, 2020
Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CMLHarald Herrmann, Irina Sadovnik, Gregor Eisenwort, et al.
Blood|July 19, 2018
CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosisNiklas Mueller, Daniel Wicklein, Gregor Eisenwort, et al.
Cancers|July 9, 2022
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in <i>KIT</i> D816V<sup>+</sup> Neoplastic Mast CellsMathias Schneeweiss-Gleixner, Yüksel Filik, Gabriele Stefanzl, et al.
Frontiers in Pediatrics|March 11, 2020
A Multidisciplinary Intervention in Childhood Obesity Acutely Improves Insulin Resistance and Inflammatory Markers Independent From Body CompositionErnst Mayerhofer, Franz Ratzinger, Nina Elvira Kienreich, et al.
American Journal of Hematology|July 7, 2022
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph<sup>+</sup> chronic myeloid leukemiaBarbara Peter, Gregor Eisenwort, Irina Sadovnik, et al.
Plos One|July 26, 2017
Fasting metabolism modulates the interleukin-12/interleukin-10 cytokine axisJohannes J Kovarik, Elisabeth Kernbauer, Markus A Hölzl, et al.
Haematologica|February 14, 2018
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosisMathias Schneeweiss, Barbara Peter, Siham Bibi, et al.
American Journal of Cancer Research|March 10, 2023
Antineoplastic efficacy profiles of avapritinib and nintedanib in <i>KIT</i> D816V<sup>+</sup> systemic mastocytosis: a preclinical studyLina Degenfeld-Schonburg, Susanne Gamperl, Gabriele Stefanzl, et al.
Blood|August 11, 2020
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosisGeorg Greiner, Bettina Sprinzl, Aleksandra Górska, et al.
Pageof 6